Solara Active Pharma Sciences Limited has made a significant announcement regarding its Rights Issue. The Rights Issue Committee of the Board of Directors has approved the first call on partly paid-up equity shares. This update will directly impact shareholders and potential investors, making it a crucial event in the stock market.
📜 Key Highlights from the Announcement
-
Company Name: Solara Active Pharma Sciences Limited
-
Stock Symbols: BSE: 541540, 890202 | NSE: SOLARA, SOLARAPP
-
Nature of Announcement: First call on partly paid-up equity shares
-
Issue Price: ₹375 per share (₹10 face value + ₹365 premium)
-
First Call Amount: ₹3.50 per share (35% of the face value)
-
Total Number of Shares Affected: 1,19,98,755
-
Record Date: April 4, 2025
-
Call Payment Period: April 16 – April 30, 2025
-
Modes of Payment: Online ASBA, Physical ASBA, 3-in-1 trading demat account
📈 Market Impact and Investor Sentiment
This move will have several effects on the stock market:
✅ Liquidity Impact: Investors who hold these partly paid-up shares will need to make additional payments, which may influence short-term liquidity.
✅ Stock Price Volatility: The announcement might cause fluctuations in share prices due to increased investor activity.
✅ Long-term Stability: The additional capital raised strengthens the company’s financial position, improving growth prospects.
✅ Investor Confidence: Shareholders may view this as a positive step toward financial discipline and structured capital management.
🏢 About Solara Active Pharma Sciences
Solara Active Pharma Sciences Limited is a prominent pharmaceutical company focused on Active Pharmaceutical Ingredients (APIs) and other pharma-related services. Headquartered in Mumbai, India, with operational facilities in Chennai, the company plays a crucial role in supplying high-quality APIs for various healthcare applications.
💡 Stay updated with stock market moves that matter! Follow for real-time investment insights!
📉 Stock Market Disclaimer
Disclaimer: This post is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy/sell any stock or share. Investing in the stock market involves risk. Past performance is not indicative of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.
